Search results for " Biopharm"
Article
Top Process Development Trends for 2022 and a Look into 2023
With certainly, the digital era has made a home in biopharmaceutical manufacturing. With heavy investment in Industry 4.0., process practices are being swept along with this rising tide. In the same w…
Article
Chromatography for the Diversified Antibody Pipeline
About 25 percent of the biopharmaceuticals are not pure antibodies they are variants. We have experienced development in the scientific environment where a lot can be done. For example, you are able t…
Article
Upstream Processing: Biochemicals and Raw Materials
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
…
Article
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
Regulatory authorities and biopharma companies are engaged in a range of collaborations to harmonize research methods, approval standards, and quality production methods key to expandi…
Article
Accelerating the Development of mRNA Therapeutics
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
READ FULL ARTICLE >>
Article
Approaches to scaling up Chromatography Processes
Scaling up chromatography resins requires a thorough understanding of their intended use.
READ FULL ARTICLE >>
Article
Cytiva Acquires Chromatography Resins Manufacturing Facility in Muskegon, Michigan
Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.
LEARN MORE >>
Article
Do Modeling and Simulation Tools Really Benefit the Biosimilar Industry?
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
READ THE FULL ARTICLE >>…
Article
Bispecific Antibodies are Moving from Research to Clinical Development
With recent approvals of bispecific antibodies, these complex molecules are fast moving out of the research box and into clinical pipelines.
READ MORE >>
Article
Tools and methodologies for smarter downstream process development
In this video, John Scibetta, Advanced Chromatography Specialist at Cytiva, is interviewed by BioPharm International and answers the following questions:
What do we mean when we say “Smar…